期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

国内埋藏式心脏转复除颤器临床应用面临的问题 被引量：4

下载PDF
导出
摘要 国内埋藏式心脏转复除颤器(ICD)临床应用率很低。存在的问题主要包括医生对ICD适应证不知晓、过分相信其他疗法在预防心脏性猝死中的作用、患者对心脏性猝死缺乏了解,医疗保险报销比例太低、如何筛选高危患者和ICD的使用寿命和更换问题等。并对相应的问题提出了诸如扩大适应证宣传等解决策略。
作者 宿燕岗
机构地区 复旦大学附属中山医院心脏内科
出处 《中国心脏起搏与心电生理杂志》 2012年第5期377-380,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 中国 综述 埋藏式心脏转复除颤器 临床应用 问题
分类号 R318.11 [医药卫生—生物医学工程]
  • 相关文献

参考文献12

  • 1Hua W, Zhang LF, Wu YF, et al. Incidence of sudden cardiac death in China: analysis of 4 regional populations [ J ]. J Am Coil Cardiol, 2009,54(12) :1 110.
  • 2Epstein AE, Kay GN, Plumb V J, et al. Implantable cardioverter-defibrillator prescription in the elderly [ J ]. Heart Rhythm, 2009,6 (8) :1 136.
  • 3宿燕岗,吴妍,柏瑾,王蔚,葛均波.植入型心律转复除颤器适应证患者及主管医生的问卷调查[J].中华心律失常学杂志,2010,14(1):59-62. 被引量：10
  • 4Bunch TJ, May HT, Bair TL, et al. Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to de- termine ICD candidacy [ J ]. Heart Rhythm, 2011,8 (9) : 1 460.
  • 5AI-Khatib SM, Hellkamp AS, Lee KL, et al. Implantable cardioverter defibrillator therapy in patients with prior coronary revascular- ization in the Sudden Cardiac Death in Heart Failure Trial ( SCD- Hell'F) [ J ]. J Cardiovasc Electrophysiol, 2008,19 (10) : 1 059.
  • 6Sudzinova A, Stancak B, Sedlak J, et al. The effect of myocardial revascularization on malignant ventricular arrhythmias in coronary artery disease [ J ]. Bratisl Lek Listy,2009,110 (4) : 226.
  • 7Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [ J ]. N Engl J Med, 2005,352 ( 3 ) : 225.
  • 8Zipes DP, Carom AJ, Borggrefe M, et al. ACC/AHA/ESC 2006Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : a report of the Ameri- can College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) : developed in collaboration with the Euro- pean Heart Rhythm Association and the Heart Rhythm Society[ J]. Circulation,2006,14 (10) : e385.
  • 9van Welsenes GH, van Rees JB, Borleffs C J, et al. Long-term follow-up of primary and secondary prevention implantable eardioverter defibrillator patients [ J ]. Europace ,2011,13 ( 3 ) : 389.
  • 10Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized mnlticenter trial of empirical antitachycardia pacing remus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators: PainFREE RxlI Trial Results [J]. Circulation, 2004,110:2 591.

二级参考文献9

  • 1Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation ,2002,106:2145-2161.
  • 2Swedberg K, Cleland J, Dargie H, et al. Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005 ) :The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur Heart J ,2005,26 : 1115-1140.
  • 3Connolly S J, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study(CIDS) :A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000, 101 : 1297-1301.
  • 4The Antiarrhythmics Verus Implantable Defibrillaton (AVID)Investigators. A comparison of Antiarrhythmic2drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 1997,337:1576-1583.
  • 5Kuck KH, Cappao R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resudcitated from cardiac arrest. The cardiac arrest study Hamburg ( CASH ). Circulation, 2000,102 : 748 -753.
  • 6Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med ,2005,352:225-237.
  • 7Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure( COMPANION ) trial. J Am Coil Cardiol,2005 ,46 :2311-2321.
  • 8ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. J Am Coil Cardiol, 2008,51 : 2085 -2105,.
  • 9Brown DW, Croft JB, Greenlund KJ, et al. Trends in hospitalization for the implantation of cardioverter-defibrillators in the Uniled States, 1990-2005. Am J Cardiol,2008,101 : 1753-1755.

共引文献9

同被引文献33

  • 1Uther J F. The automatic implantable defibrillator is the most realistic and cost-effective way of preeenting sudden cardiac [J]. Aust N Z J Med, 1992, 22(5 Suppl) : 636-638.
  • 2Hua W, Zhang L F, Wu Y F, et al. Incidence of sudden cardiac death in China : Analysis of 4 regional populations [J]. J Am Coil Cardiol, 2009,54(12) : 1110 -1118.
  • 3Muhicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction [J]. N Engl J Med, 1983,309(5) :331-336.
  • 4Solomon S D, Zelenkofske S, MeMurray J J, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both [J]. N Engl J Med, 2005,352 (25) : 2581-2588.
  • 5Daubert J P, Zareba W, Cannom D S, et al. Inappropriate implantable cardioverter-defibriilator shocks in MADIT-II : frequency, mechanisms, predictors, and survival impact [J]. J Am Coil Cardiol, 2008,51(14) : 1357- 1365.
  • 6Van der Heijden AC, Borleffs CJ, Buiten MS, et al. The clini- cal course of patients with implantable cardioverter-defibrilla- tots: extended experience on clinical outcome, device replace- ments, and device-related complications[J]. Heart Rhythm, 2015, 12(6):1 169.
  • 7Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopa- thy[J]. NEnglJ Med, 2004, 350(21):2 151.
  • 8Daubert JP, Zareba W, Cannom DS, et al. Inappropriate im- plantable eardioverter-defibrillator shocks in MADIT II.. fre- quency, mechanisms, predictors, and survival impact [J]. J Am Coll Cardiol, 2008, 51(14):1 357.
  • 9Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic im- portance of defibrillator shocks in patients with heart failure [J]. NEnglJ Med, 2008, 359(10):1 009.
  • 10Kolb C, Sturmer M, Sick P,et al. Reduced risk for inappropri- ate implantable cardioverter-defibrillator shocks with dual- chamber therapy compared with single-chamber therapy: re- suits of the randomized OPTION study[J]. JACC Heart Fail, 2014,2(6) :611.

引证文献4

二级引证文献13

中国心脏起搏与心电生理杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部